Consistent with BRCA2 and ATM showing association with disease severity, their effect sizes were larger in this aggressive prostate cancer versus controls analysis compared to the overall prostate cancer versus controls analysis (Fig. 2 and Table 2). The gene discussed is BRCA2; the disease is Familial prostate cancer.